Global Information
회사소개 | 문의
SALE

중국의 면역진단 시장(2016-2020년)

Immunodiagnostics Market in China 2016-2020

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2015년 11월 상품 코드 338879
페이지 정보 영문 103 Pages
가격
US $ 2,500 US $ 2,250 ₩ 2,563,600 PDF by E-mail (Single user license) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 US $ 2,750 ₩ 3,133,300 PDF by E-mail (5-user license) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 US $ 3,750 ₩ 4,272,700 PDF by E-mail (Enterprise license) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,000 US $ 5,000 ₩ 5,697,000 PDF by E-mail (Global license) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다. 또한 해당 라이선스는 보고서 컨텐츠의 15% 이내로 외부용 문서에 인용 게재가 허용됩니다(예:프레스릴리스, 마케팅 자료, 백서 등).


중국의 면역진단 시장(2016-2020년) Immunodiagnostics Market in China 2016-2020
발행일 : 2015년 11월 페이지 정보 : 영문 103 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

중국의 면역진단 시장은 2020년까지 연평균 성장률(CAGR)이 약 18%에 이를 전망입니다. 엄격한 의료 개혁 실시, 국내 진단 장비 제조업체의 인기 상승, 시장 경쟁 심화, 도시화 진전에 따른 만성질환(암, 당뇨병, 심혈관질환, 폐렴 등) 환자 증가 등이 시장 성장 주요인입니다. 진단 기술별로는 화학발광면역측정(CLIA) 검사가 가장 높은 점유율을 차지하고 있습니다. 제품 종류별로는 각종 시약이 시장 전체의 약 82%를 구성하고 있습니다.

중국 국내의 면역진단(Immunodiagnostic) 시장을 분석했으며, 시장 및 의료제도 개요와 구조, 시장 규모 동향(향후 5년간 예측), 제품 종류별·진단 기술별 상세 동향, 시장 성장 촉진요인 및 억제요인과 영향력, 주요 기업 개요, 향후 시장 기회 등의 정보를 전해드립니다.

제1장 개요

  • 분석 결과 개요

제2장 분석 범위

  • 분석 개요
  • 대형 벤더의 주요 제품

제3장 시장 분석 방법

  • 분석 방법
  • 경제지표

제4장 서론

  • 시장 동향 개요

제5장 중국의 의료제도

  • 중국의 건강보험제도
  • 중국의 규제 환경
  • 중국 국내의 유통 네트워크

제6장 시장 환경

  • 시장 개요
  • 시장 규모와 예측
  • Five Forces 분석

제7장 제품 종류별 시장 세분화

  • 면역진단 시약
  • 면역진단용 장비
  • 중국 국내의 면역진단 시약 시장
  • 중국 국내의 면역진단용 장비 시장

제8장 분석기 종류별 시장 세분화

제9장 조작 모드별 시장 세분화

제10장 진단 기술별 시장 세분화

  • 화학발광면역측정(CLIA) 시장
  • 효소결합면역흡착측정(ELISA) 시장
  • 형광면역측정(FIA) 시장
  • 다중면역측정(MIA) 시장
  • 측방유동면역측정(LFIA) 시장
  • 방사선면역측정(RIA) 시장

제11장 시장 성장 촉진요인

제12장 성장 촉진요인과 영향력

제13장 시장이 해결해야 할 과제

제14장 시장 성장 촉진요인 및 과제의 영향력

제15장 시장 동향

제16장 벤더 환경

  • 시장 점유율 분석
  • Tier 1 벤더 분석

제17장 주요 벤더 분석

  • Abbott Diagnostics
  • Beckman Coulter Trading(China)
  • bioMrieux China
  • DiaSorin
  • Mindray
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics(Shanghai)
  • Sysmex Medical Electronics(Shanghai)

제18장 부록

  • 약어집

제19장 Technavio 소개

도표

LSH 15.12.01

Covering: This market research report includes a detailed segmentation of the immunodiagnostic market in China by technology type (CLIA, ELISA, FIA, MIA, LFIA, and RIA), by product (reagent and instrument), by analyzer type (standalone analyzer and integrated analyzer), and by mode of operation (automated systems, semi-automated systems, and manual systems). The key vendors in this report are Roche Diagnostics, Abbott Diagnostics, Siemens Healthcare Diagnostics, Beckman Coulter, and Sysmex Medical Electronics.

Market outlook of the immunodiagnostic market in the China

Technavios market research analyst estimates the immunodiagnostics market in China to grow at an impressive CAGR of around 18% by 2020. The introduction of stringent healthcare reforms, growing preference for local manufacture of diagnostic devices, and rapidly increasing competition are some of the significant factors that augment growth in this market during the forecast period.

The rising prevalence of infectious and chronic diseases in this region is the primary growth driver for this market. In China, urbanization has led to an increase in the prevalence of chronic diseases like cancer, diabetes, cardiovascular diseases, and tuberculosis. This high prevalence of chronic diseases is envisaged to bolster the need for immunodiagnostic tests, which in turn would result in market growth during the forecast period.

Competitive landscape and key vendors

The immunodiagnostic market in the China is consolidated due to the presence of numerous small, medium, and large vendors. The vendors in this market compete on the basis of product differentiation, application differentiation, portfolio, and pricing to gain maximum market traction during the forecast period.

The top vendors in the market are -

  • Roche Diagnostics
  • Abbott Diagnostics
  • Siemens Healthcare Diagnostics
  • Beckman Coulter
  • Sysmex Medical Electronics (Shangai)

Other prominent vendors in the market include AccuBio Tech,Alere,Becton Dickinson,Beijing Kewei Clinical Diagnostics Reagents, Beijing Leadman Biochemistry,Bio-RadBioscience Diagnostic Technology,Biosino Biotechnology & Science, DIAsource, DiaSys Diagnostic Systems, Fosun Pharma, Getein Biotechnology, Hitachi, Immunodiagnostic System Holdings, Luminex, NewScen Coast Bio-Pharmaceutical, Ortho Clinical Diagnostics, Shanghai Kehua Bio-engineering, Sichuan Maccura Biotechnology, Tecan, and Thermofisher Scientific.

Technological segmentation of the immunodiagnostic market in China

  • ELISA
  • CLIA
  • RIA
  • FIA
  • MIA
  • LFIA

According to this global market research report, the chemiluminescence (CLIA) assay segment is anticipated to be the largest market segment during the forecast period. The ability of this assay to perform clinical applications at a rapid pace is a major factor that augments its adoption during the forecast period. Moreover, this assays ability to make sample detection sensitive and easy is envisaged to result in its profound market share of more than 66% by 2020.

Product-type segmentation and analysis of the immunodiagnostic market in China

  • Reagent
  • Instrument

Technavio market research analysts estimate the reagents segment to account for a market share of approximately 82% during the forecast period. The ability of reagents to diagnose minute quantities of biological agents like hormones, viruses, vitamins, or immunogenic substances in blood samples is anticipated to result in its high adoption during the predicted period.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2020
  • What are the key factors driving the immunodiagnostic market in the China
  • What are the key market trends impacting the growth of the immunodiagnostic market in the China
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the vendors in the immunodiagnostic market in the China
  • What are the key outcomes of the five forces analysis of the immunodiagnostic market in the China

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Healthcare system in China

  • Health insurance system in China
  • Regulatory landscape of China
  • Distribution network in China

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Market segmentation by product type

  • Immunodiagnostic reagents
  • Immunodiagnostic instruments
  • Immunodiagnostic reagents market in China
  • Immunodiagnostic instruments market in China

PART 08: Market segmentation by analyzer type

PART 09: Market segmentation by mode of operation

PART 10: Market segmentation by technology

  • CLIA market in China
  • ELISA market in China
  • FIA market in China
  • MIA market in China
  • LFIA market in China
  • RIA market in China

PART 11: Market drivers

PART 12: Impact of drivers

PART 13: Market challenges

PART 14: Impact of drivers and challenges

PART 15: Market trends

PART 16: Vendor landscape

  • Market share analysis
  • Analysis of tier 1 vendors

PART 17: Key vendor analysis

  • Abbott Diagnostics
  • Beckman Coulter Trading (China)
  • bioMrieux China
  • DiaSorin
  • Mindray
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics (Shanghai)
  • Sysmex Medical Electronics (Shanghai)

PART 18: Appendix

  • List of abbreviations

PART 19: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Hospital distribution in China 2015
  • Exhibit 03: Hospital segmentation in China
  • Exhibit 04: Distribution of healthcare institutions in China
  • Exhibit 05: Health insurance system in China
  • Exhibit 06: Regulatory process for approval of medical devices in China
  • Exhibit 07: Distribution network in China 2013
  • Exhibit 08: Immunodiagnostics market in China
  • Exhibit 09: Immunodiagnostics market in China 2015-2020 ($ millions)
  • Exhibit 10: Five forces analysis
  • Exhibit 11: Immunodiagnostics market in China by product type
  • Exhibit 12: Segmentation of immunodiagnostics market in China by product type 2015
  • Exhibit 13: Segmentation of immunodiagnostics market in China by product type 2020
  • Exhibit 14: Immunodiagnostic reagents market in China market 2015-2020 ($ millions)
  • Exhibit 15: Immunodiagnostic instruments market in China 2015-2020 ($ millions)
  • Exhibit 16: Segmentation of immunodiagnostics market in China by analyzer type
  • Exhibit 17: Segmentation of immunodiagnostics market in China by analyzer type 2015
  • Exhibit 18: Segmentation by mode of operation
  • Exhibit 19: Segmentation of immunodiagnostics market in China by mode of operation 2015
  • Exhibit 20: Segmentation of the immunodiagnostics market in China by technology
  • Exhibit 21: Segmentation of immunodiagnostics market by technology 2015
  • Exhibit 22: Segmentation of immunodiagnostics market by technology 2020
  • Exhibit 23: CLIA market in China 2015-2020 ($ millions)
  • Exhibit 24: ELISA market in China 2015-2020 ($ millions)
  • Exhibit 25: FIA market in China 2015-2020 ($ millions)
  • Exhibit 26: MIA market in China 2015-2020 ($ millions)
  • Exhibit 27: LFIA market in China 2015-2020 ($ millions)
  • Exhibit 28: RIA market in China 2015-2020 ($ millions)
  • Exhibit 29: Segmentation of immunodiagnostics market in China by technology 2015-2020
  • Exhibit 30: Impact of drivers
  • Exhibit 31: Impact of drivers and challenges
  • Exhibit 32: Competitive positioning of vendors
  • Exhibit 33: Abbott Diagnostics: Key takeaways
  • Exhibit 34: Beckman Coulter Diagnostics: Key takeaways
  • Exhibit 35: Roche Diagnostics: Key takeaways
  • Exhibit 36: Siemens Healthcare Diagnostics: Key takeaways
  • Exhibit 37: Abbott Diagnostics: Business segmentation
  • Exhibit 38: Beckman Coulter Trading (China): Business segmentation
  • Exhibit 39: bioMrieux China: Business segmentation
  • Exhibit 40: DiaSorin: Technology segmentation by revenue 2014
  • Exhibit 41: DiaSorin: Technology segmentation by revenue 2013 and 2014
  • Exhibit 42: DiaSorin: Geographical segmentation by revenue 2014
  • Exhibit 43: Mindray: Business segmentation by revenue 2014
  • Exhibit 44: Mindray: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 45: Mindray: Geographical segmentation by revenue 2014
  • Exhibit 46: Mindray: Geographical segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 47: Roche Diagnostics: Business segmentation by revenue 2014
  • Exhibit 48: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 49: Roche Diagnostics: Geographical segmentation by revenue 2014
  • Exhibit 50: Roche Diagnostics: Geographical segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 51: Roche Diagnostics: Sales in emerging markets
  • Exhibit 52: Siemens Healthcare Diagnostics (Shanghai): Business segmentation
  • Exhibit 53: Sysmex Medical Electronics (Shanghai): Business segmentation by revenue 2014 (% share)
  • Exhibit 54: Sysmex Medical Electronics (Shanghai): Business segmentation by revenue 2014 and 2015 ($ millions)
  • Exhibit 55: Sysmex Medical Electronics (Shanghai): Product segmentation by revenue 2015
  • Exhibit 56: Sysmex Medical Electronics (Shanghai): Product segmentation by revenue 2014 and 2015 ($ millions)
Back to Top
전화 문의
이용안내
 
BCC Research